moxalactam has been researched along with Experimental Lung Inflammation in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (88.89) | 18.7374 |
1990's | 1 (5.56) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (5.56) | 2.80 |
Authors | Studies |
---|---|
Gao, Z; Jing, S; Luan, Y; Mu, D; Wang, D; Wang, L; Wang, T; Wang, Y; Xiang, H; Yang, P | 1 |
Johnson, CE; Pennington, JE; Platt, R | 1 |
Evans, HE; Khan, AJ; Kumar, K; Patel, U; Quaye, G; Varghese, M | 1 |
McCall, CE; Pegram, PS; Salzer, W | 1 |
Coomans, D; Imbert, Y; Leng, B | 1 |
Bass, JB; Bonner, JR; Hawkins, EL; Pollock, HM | 1 |
Avent, CK; Cobbs, CG; Dismukes, WE; Elliott, AM; Livingston, WK | 1 |
Lentino, JR; Moore, E; Rytel, MW | 1 |
Chandrasekar, PH; Chokkavelu, V; Kannangara, DW; Le Frock, JL; Rolston, KV | 1 |
Bouza, E; Guerrero, A; Hospital, JS; Loza, E; Martínez-Beltrán, J; Pérez del Rio, J; Rodríguez-Creixems, M | 1 |
Haruta, T; Kobayashi, Y; Kuroki, S; Okura, K | 1 |
DeMaria, A; McCabe, WR | 1 |
Fujii, M; Fukuyama, T; Nakano, T; Okamoto, K; Okuno, H | 1 |
Ikawa, M; Katoh, M; Yamane, Y | 1 |
Hosutt, JA; Lentnek, AL; McDevitt, JT; Nichols, RL; Wikler, MA | 1 |
Ackerman, BH; Rotschafer, JC; Tofte, RW | 1 |
Baird, I; Bermudez, R; Lorber, B; Noble, R; Silverblatt, F; Vasquez, G; Yangco, BG | 1 |
George, RB; Lentino, JR; O'Keefe, JP; Payne, DK; Rotschafer, J; Venezio, FR; Vereen, LE | 1 |
3 trial(s) available for moxalactam and Experimental Lung Inflammation
Article | Year |
---|---|
Clinical evaluation of moxalactam.
Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Clinical Trials as Topic; Drug Resistance, Microbial; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Moxalactam; Pneumonia; Sepsis | 1981 |
Coagulopathy associated with extended-spectrum cephalosporins in patients with serious infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefotaxime; Ceftizoxime; Cephalosporins; Double-Blind Method; Female; Humans; Hypoprothrombinemias; Male; Middle Aged; Moxalactam; Peritonitis; Pneumonia; Prothrombin Time; Random Allocation | 1987 |
Comparative efficacy and safety of ceftizoxime, cefotaxime and latamoxef in the treatment of bacterial pneumonia in high risk patients.
Topics: Aged; Aged, 80 and over; Bacterial Infections; Cefotaxime; Ceftizoxime; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Moxalactam; Pneumonia; Random Allocation; Risk | 1987 |
15 other study(ies) available for moxalactam and Experimental Lung Inflammation
Article | Year |
---|---|
The combination of salvianolic acid A with latamoxef completely protects mice against lethal pneumonia caused by methicillin-resistant
Topics: Aminoacyltransferases; Animals; Bacterial Proteins; Biofilms; Caffeic Acids; Cysteine Endopeptidases; Drug Synergism; Female; Humans; Lactates; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Moxalactam; Pneumonia; Staphylococcal Infections | 2020 |
Third-generation cephalosporins in the treatment of pneumonia due to Pseudomonas aeruginosa in guinea pigs.
Topics: Animals; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Cephamycins; Drug Evaluation, Preclinical; Guinea Pigs; Moxalactam; Pneumonia; Pseudomonas Infections; Ticarcillin; Tobramycin | 1982 |
Clinical and pharmacokinetic evaluation of moxalactam in infants and children.
Topics: Adolescent; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Female; Half-Life; Humans; Infant; Kidney Function Tests; Kinetics; Liver Function Tests; Male; Moxalactam; Pneumonia; Urinary Tract Infections | 1982 |
Clinical evaluation of moxalactam: evidence of decreased efficacy in gram-positive aerobic infections.
Topics: Adolescent; Adult; Aged; Anaerobiosis; Bacteria; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Female; Humans; Infant; Male; Meningitis; Middle Aged; Moxalactam; Peritonitis; Pneumonia; Sepsis; Urinary Tract Infections | 1983 |
[The French experience with moxalactam in pneumology].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Bronchitis; Bronchopneumonia; Cephalosporins; Cephamycins; Female; France; Humans; Injections, Intramuscular; Male; Middle Aged; Moxalactam; Pneumonia; Respiratory Tract Infections | 1983 |
Use of a bronchoscopic protected catheter technique in the clinical evaluation of a new antibiotic.
Topics: Bacteria; Bacteriological Techniques; Bronchoscopy; Catheterization; Evaluation Studies as Topic; Haemophilus Infections; Haemophilus influenzae; Humans; Moxalactam; Pneumonia; Pneumonia, Pneumococcal; Sepsis; Sputum; Streptococcus pneumoniae | 1983 |
Therapy of lower respiratory tract infections with moxalactam.
Topics: Adult; Aged; Bacteria; Bacterial Infections; Cefamandole; Cephalosporins; Cephalothin; Cephamycins; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Moxalactam; Pneumonia; Species Specificity | 1981 |
Comparative efficacy of four antibiotics in anaerobic pulmonary infection. An experimental model in rabbits.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Cefoxitin; Eubacterium; Fusobacterium Infections; Male; Metronidazole; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Peptococcus; Pneumonia; Rabbits | 1984 |
Evaluation of lamoxactam in the treatment of severe bacterial infections.
Topics: Abdomen; Adolescent; Adult; Aged; Bacterial Infections; Female; Humans; Inflammation; Male; Middle Aged; Moxalactam; Osteomyelitis; Phlebitis; Pneumonia; Sepsis; Surgical Wound Infection; Urinary Tract Infections | 1983 |
[Evaluation of latamoxef in the treatment of infections of newborn infants].
Topics: Bacterial Infections; Drug Evaluation; Female; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Male; Moxalactam; Pneumonia; Sepsis; Urinary Tract Infections | 1983 |
A clinical study of moxalactam in the treatment of infections due to gram-negative bacilli.
Topics: Adult; Aged; Drug Evaluation; Enterobacteriaceae Infections; Female; Haemophilus Infections; Humans; Male; Meningitis; Middle Aged; Moxalactam; Pneumonia; Pseudomonas Infections; Sepsis; Skin Diseases, Infectious; Urinary Tract Infections; Wound Infection | 1984 |
[A case of hematuria associated with cefem group antibiotics].
Topics: Aged; Candidiasis; Hematuria; Humans; Male; Moxalactam; Pneumonia; Pneumonia, Viral; Pseudomonas Infections | 1992 |
[Therapeutic bronchoalveolar lavage in pulmonary infections].
Topics: Adult; Aged; Bacterial Infections; Bronchoalveolar Lavage Fluid; Female; Gentamicins; Humans; Male; Middle Aged; Moxalactam; Pneumonia; Therapeutic Irrigation | 1988 |
High-dose moxalactam in gram-negative pneumonia.
Topics: Aged; Female; Gram-Negative Bacteria; Humans; Male; Middle Aged; Moxalactam; Pneumonia; Serratia marcescens | 1986 |
High-dose moxalactam in gram-negative pneumonia: efficacy and safety.
Topics: Adult; Aged; Female; Gram-Negative Bacteria; Humans; Male; Middle Aged; Moxalactam; Pneumonia; Respiratory Tract Infections | 1987 |